Professional Documents
Culture Documents
SECRETORY OTITIS MEDIA: PRESENCE OF EFFUSION IN MIDDLE EAR WITHOUT ANY S/S OF INFLAMMATION.
ACUTE OTITIS MEDIA:
MOSTLY IN CHILDREN,
SADE ET AL 1986- 22% INCIDENCE IN FIRST YEAR, 15% IN 2ND YEAR, 10% IN THIRD AND FOURTH YEAR AND 2%
IN EIGTH YEAR.
PPT FACTORS:
AGE- < 7 YEARS, (URI MORE FREQUENT, ET TUBE SHORTER AND MORE HORIZENTAL, ABUNDANT
NASOPHARYNGEAL LYMPHOID TISSUE, IMMATURE IMMUNE SYSTEM)
SEASONAL CHANGE-
BREASTFEEDING- LOWER INCIDENCE (COMPOSITION- ANTIBACTERIAL AND ANTIVIRAL PROPERTY, FACIAL
MUSCLE DEVELOPMENT)
RECURRENT URTI-
NASAL ALLERGY-
ADENOID HYPERTROPHY- ET TUBE BLOCKAGE, RECURRENT INFECTION
UNDERLYING CONDITION- CLEFT LIP AND PALATE, PATULOUS ET TUBE, IMMUNOSUPPRESSED CONDITION
MICROBIOLOGY:
BACTERIA- STREPTOCCUS PNEUMONIAE, HAEMOPHILUS INFLUENZAE, MORAXELLA CATARAHLIS
ACUTE OTITIS MEDIA:
CLINICAL STAGES:
1. TUBAL OCCLUSION STAGE-
NASOPHARYNGEAL END OF ET TUBE OEDEMATOUS, EARACHE, LOSS OF CONE OF LIGHT, FORESHORTENED
HOM
2. PRE-SUPPURATIVE STAGE-
ASCENDING INFECTION VIA THE LUMEN OR SUBEPITHELIAL LYMPHATICS OF ET TUBE, FEVER WITH
THROBBING EARACHE, CART WHEEL APPEARANCE FOLLOWED BY FULL CONGESTION
STAGE OF HYPERAEMIA-
STAGE EXUDATION: FROM DIALATED CAPILLARIES OF MIDDLE EAR CLEFT (FIBRIN, PMN) AND METAPLASTIC
GOBLET CELLS
3. SUPPURATIVE STAGE-
FORMATION OF PUS IN MIDDLE EAR, FEVER & EARACHE, MAY BE A PUS POINT
4. RESOLUTION STAGE-
WITH OR WITHOUT PERFORATION AS A SEQUALAE
5. COMPLICATION STAGE-
COALESCENCE OF MASTOID AIR CELLS: HYPERAEMIC DECALCIFICATION AND OSTEOCLASTIC ACTIVITY,
PERSISTENT EAR DISCHARGE
FACIAL PALSY
MASKED MASTOIDITIS
PROGRESSION TO SOM
LABYRINTHITIS
ACUTE OTITIS MEDIA:
TREATMENT:
ANTIBACTERIAL SUPPORT- START EMPERICALLY, REVIEW AFTER 48-72 HOURS, CHANGE AND AGAIN REVIEW AFTER
10 DAYS
ANALGESIC AND ANTIPYRETIC-
NASAL DECONGESTANT DROPS-
ORAL NASAL DECONGESTANT-
MYRINGOTOMY- SURGICAL EVACUATION OF PUS
INDICATIONS OF MYRINGOTOMY:
SEVERE OTALGIA, TOXIC CHILD
IMPENDING PERFORATION
PRESENCE OF COMPLICATION
POOR RESSPONSE, PERSISTENT INFLAMMATION BEYOND 12 WEEKS
MYRINGOTOMY:
INCISION IN THE ANTERO-INFERIOR QUADRANT, CIRCUMFERENTIAL INCISION, WITH A MYRINGOTOME
ACUTE NECROTIZING OTITIS MEDIA:
BETWEEN 6 MONTHS TO 6 YEARS OF AGE,ATTACKS 4/5 TIMES A YEAR, MOST LIKELY WITH UNDERLYING
PATHOLOGY I.E. VELOPHARYNGEAL INSUFFICIENCY, ADENOID HYPERTROPHY, ENLARGED TONSILS, NASAL ALLERGY,
IMPROPER FEEDING POSTURE
TREATMENT- ANTIBIOTICS, MYRINGOTOMY AND GROMMET INSERTION, TREATMENT OF UNDERLYING CAUSE.
CHRONIC OTITIS MEDIA:
TYPES:
MUCOSAL- ACTIVE, INACTIVE, HEALED
SUAMOUS- ACTIVE, INACTIVE
WHAT IS A PERMANENT PERFORATION?
VARIOUS TYPES OF PERFORATION- PARS TENSA (CENTRAL, MARGINAL), PARS FLACCIDA
CLINICAL PRESENTATION:
EAR DISCHARGE- MUCOSAL VS SQUAMOUS DISEASE
HEARING LOSS- AUTO Type III, SHIELDING EFFECT, CHOLESTEATOMA HEARER
APPROACH TO DIAGNOSIS:
EUM, MICROBIOLOGY, PTA, RADIOLOGY, PAC TESTS
CLASSIFICATION-
CONGENITAL- DERLACKI AND CLEMIS CRITERIA
AQUIRED-
PRIMARY- WITTMACK’S INVAGINATION THEORY, RUEDI’S BASAL CELL HYPERPLASIA THEORY, SADE’S
METAPLASIA THEORY
SECONDARY- HABERMANN’S EPITHELIAL MIGRATION THEORY, SADE’S METAPLASIA THEORY
MIDDLE EAR IS A GAS FILLED (0.5 ML) STRUCTURE TO ALLOW LEAST RESISTANCE FOR THE OSSICLES, ALMOST
SIMILAR TO AIR PRESSURE OF EAC FOR OPTIMAL SOUND TRANSFER
1 -2 MICROLIT GAS PER MINUTE LOST FROM MIDDLE EAR VIA DIFFUSION INTO SURROUNDING CIRCULATION
BALANCED BY ET TUBE SPONTANEOUSLY OPENING (VIA SWALLOWING) ALMOST 1000 TIMES A DAY, ENTRY OF 1 -2
ML AIR INTO MIDDLE EAR EVERY DAY BY ET TUBE ACTION
MASTOID AIR RESERVE RANGE 1ML TO 30ML DEPENDING ON PNEUMATISATION, BUFFERS PRESSURE CHANGE
INSIDE MIDDLE EAR CLEFT, (MIDDLE EAR ONLY EXCEPT MASTOID AIR CELL SYSTEM HAS ONLY 0.5 ML AIR RESERVE)
BLOCK IN ET/ POOR PNEUMATISATION LEADS TO POOR VENTILATION AND ABSORPTION OF AIR FOLLOWED BY
TYMPANIC MEMBRANE RETRACTION
GRADES OF PARS TENSA AND STAGES OF PARS FLACCIDA RETRACTION
BIOFILM:
PROTECTIVE POLYSACCHARIDE COAT SECRETED BY BACTERIA ITSELF/ BACTERIAL COLONY WHEN BACTERIA ATTACHES
TO A ORGANIC/ INORGANIC SURFACE
PROTECTS FROM PHAGOCYTOSIS AND ANTIBODY IN BLOOD, BUT PROVIDES NUTRITION
PERSISTS ON TYMPANOSTOMY TUBE, TONSIL/ ADENOID
PREVENTED BY ANTIBIOTIC COATED TYMPANOSTOMY TUBE